Literature DB >> 7361631

The cholinergic system in old age and Alzheimer's disease.

E K Perry.   

Abstract

Activities relating to the cholinergic system in post-mortem brain tissue have been examined in relation to ageing and Alzheimer-type pathology. As senile plaque numbers increased in non-demented and demented old people, activities of choline acetyltransferase and acetylcholinesterase decreased, butyrylcholinesterase increased and muscarinic receptor binding remained unchanged. The behaviour of these biochemical activities was further examined in relation to the ageing process in mentally normal people. Loss of choline acetyltransferase also occurred, to a lesser extent, with increasing age and muscarinic binding decreased but there was no age-related loss in acetylcholinesterase. These biochemical findings are discussed in relation to the possible involvement of the cholinergic system in 'normal' ageing and in Alzheimer's disease and are compatible with an extension of age-related nerve terminal changes to abnormalities of cholinergic processes in the disease itself.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7361631     DOI: 10.1093/ageing/9.1.1

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  42 in total

1.  Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia.

Authors:  E D London; M J Ball; S B Waller
Journal:  Neurochem Res       Date:  1989-08       Impact factor: 3.996

Review 2.  Regulation of cortical acetylcholine release: insights from in vivo microdialysis studies.

Authors:  Jim R Fadel
Journal:  Behav Brain Res       Date:  2010-02-16       Impact factor: 3.332

3.  Scopolamine and the control of attention in humans.

Authors:  M P Dunne; L R Hartley
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.

Authors:  Michel Grothe; Helmut Heinsen; Stefan J Teipel
Journal:  Biol Psychiatry       Date:  2011-08-04       Impact factor: 13.382

Review 5.  Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.

Authors:  Gohar Mushtaq; Nigel H Greig; Jalaluddin A Khan; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

6.  A meta-analysis of the effects of aging on motor cortex neurophysiology assessed by transcranial magnetic stimulation.

Authors:  Apoorva Bhandari; Natasha Radhu; Faranak Farzan; Benoit H Mulsant; Tarek K Rajji; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  Clin Neurophysiol       Date:  2016-06-08       Impact factor: 3.708

7.  Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core.

Authors:  M N Rossor
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-12

Review 8.  Pharmacodynamic effects and possible therapeutic uses of THIP, a specific GABA-agonist.

Authors:  A V Christensen; O Svendsen; P Krogsgaard-Larsen
Journal:  Pharm Weekbl Sci       Date:  1982-10-22

Review 9.  Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease.

Authors:  S Hunter; C Brayne
Journal:  Mol Psychiatry       Date:  2017-11-07       Impact factor: 15.992

10.  Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease.

Authors:  Michel Grothe; Helmut Heinsen; Stefan Teipel
Journal:  Neurobiol Aging       Date:  2012-11-15       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.